Insider Transactions in Q4 2022 at Bio Cardia, Inc. (BCDA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2022
|
Phillip Md Et Al Frost > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
595,238
+22.71%
|
$595,238
$1.68 P/Share
|
|
Dec 16
2022
|
David Mc Clung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,928
+9.26%
|
$8,928
$1.68 P/Share
|
|
Dec 16
2022
|
Simon H Stertzer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
178,571
+16.74%
|
$178,571
$1.68 P/Share
|
|
Dec 16
2022
|
Peter Altman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,880
+4.1%
|
$14,880
$1.68 P/Share
|
|
Dec 16
2022
|
Andrew Scott Blank Director |
BUY
Grant, award, or other acquisition
|
Indirect |
148,809
+33.78%
|
$148,809
$1.68 P/Share
|
|
Dec 16
2022
|
Jim L. Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
148,809
+15.19%
|
$148,809
$1.68 P/Share
|
|
Oct 10
2022
|
David Mc Clung Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+2.48%
|
$4,000
$2.07 P/Share
|